Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Penning

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Drug Discovery & Development|September 3, 2010
Small-molecule PARP modulators--current status and future therapeutic potentialThomas D Penning
Journal of Pharmaceutical Sciences|October 5, 2024
Improving oral absorption of a rapidly crystallizing parent drug using prodrug strategy: Comparison of phosphate versus glycine based prodrugsAnura S Indulkar, Russell Slade, Navendu Jana, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancerViraj B Gandhi, Yan Luo, Xuesong Liu, et al.
Journal of the Peripheral Nervous System : JPNS|September 14, 2012
PARP inhibitors attenuate chemotherapy-induced painful neuropathyJill-Desiree Brederson, Shailen K Joshi, Kaitlin E Browman, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2019
Investigation of biaryl heterocycles as inhibitors of Wee1 kinaseAnthony Mastracchio, Chunqiu Lai, Maricel Torrent, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Drug Discovery & Development|September 3, 2010
Small-molecule PARP modulators--current status and future therapeutic potentialThomas D Penning
Journal of Pharmaceutical Sciences|October 5, 2024
Improving oral absorption of a rapidly crystallizing parent drug using prodrug strategy: Comparison of phosphate versus glycine based prodrugsAnura S Indulkar, Russell Slade, Navendu Jana, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancerViraj B Gandhi, Yan Luo, Xuesong Liu, et al.
Journal of the Peripheral Nervous System : JPNS|September 14, 2012
PARP inhibitors attenuate chemotherapy-induced painful neuropathyJill-Desiree Brederson, Shailen K Joshi, Kaitlin E Browman, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2019
Investigation of biaryl heterocycles as inhibitors of Wee1 kinaseAnthony Mastracchio, Chunqiu Lai, Maricel Torrent, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Pageof 4